Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands
- PMID: 20104550
- DOI: 10.1002/chem.200902312
Cytotoxic titanium salan complexes: surprising interaction of salan and alkoxy ligands
Abstract
The synthesis, biochemical evaluation, and hydrolysis studies of a wide selection of alkyl- and halogen-substituted titanium salan alkoxides are presented herein. A systematic change in the employed alkoxides revealed that both the bulk of the salan ligands and the steric demand of the labile ligands are of great importance for the obtained biological activity. Surprisingly, these two factors are not independent from each other; lowering the steric demand of the alkoxide of a hitherto nontoxic complex renders it cytotoxic. Therefore, our data suggest that the overall size of the complex exerts a strong influence on its biological activity. To decide whether the correlation between the cytotoxicity and the steric demand of the whole complex is merely based on an altered hydrolysis or on the interaction with biomolecules, the behavior of selected complexes under hydrolytic conditions and the influence of transferrin were investigated. Complexes differing only in their labile alkoxy ligands gave the same hydrolysis products with similar hydrolysis rates but displayed cytotoxicities that differed in the range of one order of magnitude. Thus, it seems that the hydrolysis product is not the active species but rather that the unhydrolysed complex is important for the first interaction with a biomolecule. This promoted the idea of hydrolysis being a detoxification pathway. In accordance with the above conclusion, chloro-substituted complex [Ti(Ph(Cl)N(Me))(2)(O(iPr))(2)] displayed a high cytotoxicity (IC(50) approximately 5 microM) and surprisingly high hydrolytic stability (t(1/2)=108 h). These findings, together with the observed cytotoxicity in a cisplatin-resistant cell line, make halo-substituted salan complexes an interesting target for further studies.
Similar articles
-
Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.Inorg Chem. 2011 Feb 7;50(3):1030-8. doi: 10.1021/ic101693v. Epub 2011 Jan 7. Inorg Chem. 2011. PMID: 21214265
-
Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.Chemistry. 2009;15(10):2403-15. doi: 10.1002/chem.200801310. Chemistry. 2009. PMID: 19156656
-
Cytotoxicity and hydrolysis of trans-Ti(IV) complexes of salen ligands: structure-activity relationship studies.Inorg Chem. 2012 Feb 6;51(3):1796-804. doi: 10.1021/ic202092u. Epub 2011 Dec 29. Inorg Chem. 2012. PMID: 22220885
-
Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.Met Ions Biol Syst. 1996;33:105-41. Met Ions Biol Syst. 1996. PMID: 8742842 Review.
-
Coordination Complexes of Titanium(IV) for Anticancer Therapy.Met Ions Life Sci. 2018 Feb 5;18:/books/9783110470734/9783110470734-014/9783110470734-014.xml. doi: 10.1515/9783110470734-014. Met Ions Life Sci. 2018. PMID: 29394027 Review.
Cited by
-
In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.ChemMedChem. 2018 Nov 6;13(21):2290-2296. doi: 10.1002/cmdc.201800551. Epub 2018 Oct 19. ChemMedChem. 2018. PMID: 30203598 Free PMC article.
-
Titanium salan complexes displays strong antitumor properties in vitro and in vivo in mice.PLoS One. 2011 Mar 21;6(3):e17869. doi: 10.1371/journal.pone.0017869. PLoS One. 2011. PMID: 21445304 Free PMC article.
-
Synthesis, in vitro antitumor evaluation and structure activity relationship of heptacoordinated amino-bis(Phenolato) Ti(IV) complexes stabilized by 2,6-dipicolinic acid.J Biol Inorg Chem. 2024 Apr;29(3):315-330. doi: 10.1007/s00775-024-02059-9. Epub 2024 May 9. J Biol Inorg Chem. 2024. PMID: 38722397
-
Cytotoxicity of a Ti(IV) compound is independent of serum proteins.Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5016-21. doi: 10.1073/pnas.1119303109. Epub 2012 Mar 12. Proc Natl Acad Sci U S A. 2012. PMID: 22411801 Free PMC article.
-
In vitro combinations of inert phenolato Ti(iv) complexes with clinically employed anticancer chemotherapy: synergy with oxaliplatin on colon cells.RSC Adv. 2018 Feb 5;8(11):5822-5827. doi: 10.1039/c8ra00229k. Epub 2018 Feb 6. RSC Adv. 2018. PMID: 30009018 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources